High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Celebioglu, EMİNE; Gurkan, OU; Erdogan, S; Savas, I; Kose, K; Kurtman, C; Gonullu, U

doi:10.1093/jjco/hyf102

High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Atıf İçin Kopyala

Celebioglu B. , Gurkan O., Erdogan S., Savas I., Kose K., Kurtman C., ...Daha Fazla

Japanese journal of clinical oncology, cilt.32, ss.443-8, 2002 (SCI Expanded İndekslerine Giren Dergi)

Cilt numarası: 32 Konu: 11
Basım Tarihi: 2002
Doi Numarası: 10.1093/jjco/hyf102
Dergi Adı: Japanese journal of clinical oncology
Sayfa Sayıları: ss.443-8

Özet

Background: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.